Rimma Driscoll - 18 Feb 2026 Form 4 Insider Report for Zoetis Inc. (ZTS)

Role
Executive Vice President
Signature
/s/ Brenda Santuccio, as Attorney-in-Fact
Issuer symbol
ZTS
Transactions as of
18 Feb 2026
Net transactions value
$0
Form type
4
Filing time
19 Feb 2026, 20:52:14 UTC
Previous filing
10 Feb 2026
Next filing
23 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Driscoll Rimma Executive Vice President C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY /s/ Brenda Santuccio, as Attorney-in-Fact 19 Feb 2026 0001952575

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZTS Restricted Stock Unit Award $0 +2,323 $0.000000 2,323 18 Feb 2026 Common Stock 2,323 Direct F1, F2, F3, F4
transaction ZTS Stock Option Award $0 +9,191 $0.000000 9,191 18 Feb 2026 Common Stock 9,191 $129.13 Direct F7, F8, F9
holding ZTS Restricted Stock Unit 1,363 18 Feb 2026 Common Stock 1,363 Direct F1, F2, F4, F5
holding ZTS Restricted Stock Unit 222 18 Feb 2026 Common Stock 222 Direct F1, F2, F4, F6
holding ZTS Stock Option 5,235 18 Feb 2026 Common Stock 5,235 $156.64 Direct F7, F9, F10
holding ZTS Stock Option 2,500 18 Feb 2026 Common Stock 2,500 $196.14 Direct F7, F9, F11
holding ZTS Stock Option 2,077 18 Feb 2026 Common Stock 2,077 $162.07 Direct F7, F9, F12
holding ZTS Stock Option 5,271 18 Feb 2026 Common Stock 5,271 Direct F9, F13, F14, F15
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs").
F2 Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.
F3 One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 18, 2026; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
F4 Not applicable.
F5 One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 19, 2025; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
F6 One-third of each RSU vests and is settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 6, 2024; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
F7 Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan.
F8 One-third of each option will vest on the first, second and third anniversaries of the date of grant, February 18, 2026.
F9 Each option expires on the tenth anniversary of the date of grant.
F10 One-third of each option will vest on the first, second and third anniversaries of the date of grant, February 19, 2025.
F11 One-third of each option vests on the first, second and third anniversaries of the date of grant, February 6, 2024.
F12 One-third of each option vested on the first, second and third anniversaries of the date of grant, February 8, 2023.
F13 Stock option (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan.
F14 1,836 options granted February 12, 2019 at an exercise price of $87.51 per option; 1,252 options granted February 11, 2020 at an exercise price of $144.03 per option; 1,206 options granted February 10, 2021 at an exercise price of $160.62; and 977 options granted February 8, 2022 at an exercise price of $201.30 per option.
F15 Each option vested on the third anniversary of the date of grant.